Skip to main content
SpringerLink
Log in

Surgery and Tumors

  • Chapter
Surgery in Multimodal Management of Solid Tumors

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 539 Accesses

Abstract

Surgery is the fundamental treatment option in most solid tumors, but it is no longer the sole therapeutic weapon available. Instead it needs to be integrated in a considerably more complex multidisciplinary strategy, with two main aims: — To guarantee recovery and increase the duration of survival through the control of the disease, not only at the local-regional level, but also in general — To guarantee good quality of life by means of the most conservative possible treatment which maintains organ function and a good image of the organism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wiggers T, Jeekel J, Arends JW et al (1988) No-touch isolation tecnique in colon cancer: a controlled prospective trial. Br J Surg 75(5):409–415

    Article  PubMed  CAS  Google Scholar 

  2. Salsbury AJ (1975) The significance of the circulating cancer cell. Cancer Treat Rev 2(1):55–72

    Article  PubMed  CAS  Google Scholar 

  3. Sugarbaker PH, Corlew S (1982) Influence of surgical techniques on survival in patients with colorectal cancer. Dis Colon Rectum 25(6):545–557

    Article  PubMed  CAS  Google Scholar 

  4. Glaves D, Hubert RP, Weiss L (1988) Hematogenous dissemination of cells from human renal carcinomas. Br J Cancer 57: 32–35

    PubMed  CAS  Google Scholar 

  5. Vlems FA, Ruers T J, Punt CJ et al (2003) Relevance of disseminated tumor in blood bone marrow of patients with solid epithelial tumors in perspective. EJSO 29:289–302

    Article  PubMed  CAS  Google Scholar 

  6. Klein CA, Blankestein TJ, Schmidr-Kittler O et al (2002) Genetic heterogenecity of single disseminated tumour cells in minimal residual cancer. Lancet 360:689–699

    Article  Google Scholar 

  7. Fisher B, Fisher ER (1967) Barrier function of lymph node to tumor cells and erythrocytes. Cancer 20:1907–1913

    Article  PubMed  CAS  Google Scholar 

  8. Isono K, Sato H, Nakayama K (1991) Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 48(5):411–420

    Article  PubMed  CAS  Google Scholar 

  9. Hermanek P, Altendorf A (1981) Classification of colorectal carcinomas with regional lymphatic metastases. Pathol Res Pract 173(1-2): 1–11

    PubMed  CAS  Google Scholar 

  10. Hermanek P, Hutter RV, Sobin LH, Wagner G (1997) International Union Against Cancer. TNM atlas, IV edition. Springer, Berlin Heidelber New York

    Google Scholar 

  11. Hermanek P, Giegel P, Dworak O (1989) Two programs for examination of regional lymph nodes in colorectal carcinoma with regard to the new pN classification. Pathos Res Pract 185:867–872

    CAS  Google Scholar 

  12. Herrera L, Villareal JR (1992) Incidence of metastases from rectal adenocarcinoma in small lymph nodes detected by a clearing tecnique. Dis Colon Rectum 35(8):783–788

    Article  PubMed  CAS  Google Scholar 

  13. Morikawa E, Yasutomi M, Shindou K et al (1994) Distribution of metastatic lymph nodes in colorectal cancer by the modified clearing method. Dis Colon Rectum 37(3):219–223

    Article  PubMed  CAS  Google Scholar 

  14. Greenson JK, Isenhart CE, Rice R et al (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with longterm survival. Cancer 73(3):563–569

    Article  PubMed  CAS  Google Scholar 

  15. Raj GV, Moreno JG, Gomella LG (1998) Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82:1419

    Article  PubMed  CAS  Google Scholar 

  16. Hayashi N, Ito I, Yanagisawa A et al (1995) Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345(8960): 1257–1259

    Article  PubMed  CAS  Google Scholar 

  17. Lindemann F, Schlimok G, Dirschell P (1992) Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 340(8821):685–689

    Article  PubMed  CAS  Google Scholar 

  18. Braun S, Pantel K, Muller P et al (2000) Cytokeratine-positive cells in bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 342:525–533

    Article  PubMed  CAS  Google Scholar 

  19. Hosh SB, Braun S, Pantel K (2001) Characterization of disseminated tumor cells. Sem Surg Oncol 20:267–271

    Google Scholar 

  20. Hansen R, Wolf N, Knuechel R et al (1995) Tumor cells on blood shed from the surgical field. Arch Surg 130:387–393

    PubMed  CAS  Google Scholar 

  21. Yamamoto K, Murae M, Yasuda M (1991) RGD-Containing peptides inhibit experimental peritoneal acceding of human ovarian cancer cells. Nippon Sanka Fujinka Gakkai Zasshi 43(12): 1687–1692

    PubMed  CAS  Google Scholar 

  22. Elias D, Gachot B, Bonvallot S et al (1997) Peritoneal carcinosis treated by complete excision and immediate postoperative intraperitoneal chemotherapy. Phase II study in 54 patients. Gastroenterol Clin Biol 21(3): 181

    PubMed  CAS  Google Scholar 

  23. Elias D, Cavalcanti A, Sabourin JC et al (1998) Results of 136 curative hepatectomies with a safety margin of less than 10mm for colorectal metastases. J Surg Oncol 69:88–93

    Article  PubMed  CAS  Google Scholar 

  24. Koo J, Fung K, Siu KF et al (1983) Recovery of malignant tumor cells from the right atrium duting hepatic resection for hepatocellular carcinoma. Surgery 52:1952–1956

    CAS  Google Scholar 

  25. Slade NS, Simmons RL, Yunis E (1975) Immunodepression after major surgery in normal patients. Surgery 78:363–372

    PubMed  CAS  Google Scholar 

  26. Elias D, Farace F, Triebel F et al (1995) Phase I-II randomized study on pre-hepatectomy recombinant inerleukin-2 in patients with metastasis carcinoma of the colon and rectum. J Am Coll Surg 181:303–310

    PubMed  CAS  Google Scholar 

  27. Baker DG, Masterson TM, Pacer R et al (1989) The influence of the surgical wound on local recurrence. Surgery 106:525–532

    PubMed  CAS  Google Scholar 

  28. Elias D, Lasser P, Rougier P et al (1987) Early adjuvant intraportal chemotheraphy after curative hepatectomy for colorectal liver metastases. A pilot study. Eur J Surg Oncol 13:247–250

    CAS  Google Scholar 

  29. Romano F, Cesana G, Berselli M et al (2004) Biological histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients. J Surg Oncol 88:240–247

    Article  PubMed  CAS  Google Scholar 

  30. Elias D (1992) La chirurgie dite de réduction tumorale: mythe ou realité? J Chir (Paris) 129:479–483

    CAS  Google Scholar 

  31. André T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351

    Article  PubMed  Google Scholar 

  32. Moertel CG, Fleming TH, Mac Donald JS et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected carcinoma. N Engl J Surg 322:352–358

    Article  CAS  Google Scholar 

  33. Elias D, Oueller JF (2001) Intraperitoneal chemohyperthermia. Rationale, technique, indication, and results. Surg Oncol Clin N Am 10:915–933

    PubMed  CAS  Google Scholar 

  34. Verwaal VC, van Ruth S, de Bree E et al (2003) Randomized trial of cytoreduction and hypertermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery with peritoneal carcinomatosis from colorectal cancer. J Clin Oncol 21:3737–3743

    Article  PubMed  Google Scholar 

  35. Elias D, Sideris I, Pocard M et al (2004) Efficacy of intraperitoneal chemohypertermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol 15:781–785

    Article  PubMed  CAS  Google Scholar 

  36. Adam R, Pascal G, Castaing D et al (2004) Tumor progression while on chemotherapy. A contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052–1064

    Article  PubMed  Google Scholar 

  37. Peeters C, de Geus LF, Wetphal JR et al (2005) Decrease in circulating anti-angiogenic factor after removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. Surgery 137:246–249

    Article  PubMed  Google Scholar 

  38. Marie P, Cluner J (1910) Frequence des metastases viscérales chez les souri cancéreuses après ablation chirurgicale de leur tumeur. Bull Assoc Fr Etud Cancer 3:19–23

    Google Scholar 

  39. Buinauskas P, Mc Donald GO, Cole Wh (1958) Role of operative stress on the resistance of the experimental animal to inoculated cancer cells. Ann Surg 148:642–650

    Article  PubMed  CAS  Google Scholar 

  40. Murthy MS, Scanlon EF, Reid JK, Yang XF (1996) Pre, peri and postoperative chemotherapy for breast cancer: is one better than the other? J Surg Oncol 61:273–277

    Article  PubMed  CAS  Google Scholar 

  41. Elias D, Bonnay M, Puizzillou JM et al (2002) Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution and tolerance. Ann Oncol 13:267–272

    Article  PubMed  CAS  Google Scholar 

  42. Elias D, Matsuhina T, Sideris L et al (2004) Heated intraoperative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 15:1558–1565

    Article  PubMed  CAS  Google Scholar 

  43. Elias D, Liberale G, Vernerey D et al (2005) Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic impact. Ann Surg Oncol 12:900–909

    Article  PubMed  Google Scholar 

  44. Elias D, Youssef O, Sideris L et al (2004) Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 86:4–9

    Article  PubMed  Google Scholar 

  45. Weed DL, Greenwald P, Cullen JW (1990) The future of cancer prevention and control. Semin Oncol 17(4):504–509

    PubMed  CAS  Google Scholar 

  46. Brown PD, Giavazzi R (1995) Matrix metalloproteinase inhibition: a review of anti-tumor activity. Ann Oncol 6(10):967–974

    PubMed  CAS  Google Scholar 

  47. Folkman J (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79:1–8

    PubMed  CAS  Google Scholar 

  48. O’Relly MS, Holmgren L, Chen C, Folkman J (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2(6):689–692

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery “P. Valdoni”, University of Rome “La Sapienza”, Azienda Policlinico Umberto I, Rome, Italy

    Antonio Bolognese

  2. Department of Surgical Oncology, “Gustave-Roussy” Institute, Villejuif, France

    Dominique Elias

Authors
  1. Antonio Bolognese
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dominique Elias
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Italia

About this chapter

Cite this chapter

Bolognese, A., Elias, D. (2009). Surgery and Tumors. In: Surgery in Multimodal Management of Solid Tumors. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-1085-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1085-7_2

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1084-0

  • Online ISBN: 978-88-470-1085-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation